On February 8, 2022 Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to synthetic biology, reported that members of the executive team will present at the following investor and industry conferences (Press release, Synlogic, FEB 8, 2022, View Source [SID1234607879]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BIO CEO & Investor Conference: Molly Harper, Chief Business Officer, will present at 10:00 am EST on Monday, February 14, 2022.
11th Annual SVB Leerink Global Healthcare Conference: Aoife Brennan, M.B. Ch.B., President and Chief Executive Officer, will participate in a Fireside Chat at 12:00 pm EST on Thursday, February 17, 2022.
A live webcast of the presentations, if available, can be accessed under "Event Calendar" in the Investors & Media section of the Company’s website. Archived versions of webcasts will be available on the Synlogic website.